Related Experiment Video
Updated: May 1, 2026
13:59
Assaying β-amyloid Toxicity using a Transgenic C. elegans Model
Published on: October 9, 2010
25.6K
A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis
Luisa Diomede1, Paola Rognoni2, Francesca Lavatelli2
1Department of Molecular Biochemistry and Pharmacology, Istituto di Ricovero e Cura a Carattere Scientifico-Istituto di Ricerche Farmacologiche "Mario Negri," Milan, Italy;
Blood
|March 26, 2014
Summary
A novel nematode model using Caenorhabditis elegans shows that amyloidogenic light-chains (LCs) from AL amyloidosis patients selectively damage heart function. This model aids in understanding LC toxicity and screening new therapies for cardiac amyloidosis.
Area of Science:
- Biomedical research
- Cardiovascular science
- Genetics and molecular biology
Background:
- Immunoglobulin light-chain (AL) amyloidosis with cardiac involvement has a poor prognosis.
- Limited therapeutic options necessitate novel experimental models for studying light-chain (LC)/heart interactions and cardiac damage.
- The nematode Caenorhabditis elegans offers a unique model due to pharyngeal-vertebrate heart evolutionary links.
Purpose of the Study:
- To establish and validate Caenorhabditis elegans as a model for studying the cardiotoxicity of amyloidogenic light-chains (LCs).
- To investigate the specific effects of LCs from AL amyloidosis patients on cardiac function using a nematode model.
- To explore potential therapeutic strategies for preventing LC-induced cardiac damage.
Main Methods:
- Utilizing Caenorhabditis elegans (C. elegans) as a model organism.
- Exposing C. elegans to light-chains (LCs) from AL amyloidosis patients with cardiomyopathy.
- Measuring pharyngeal pumping rates, worm lifespan, and mitochondrial reactive oxygen species (ROS) levels.
- Assessing the effect of antioxidant treatment on LC-induced dysfunction.
Main Results:
- Amyloidogenic LCs from AL patients with cardiomyopathy selectively reduced C. elegans pharyngeal pumping.
- This functional alteration was concentration-dependent, leading to persistent dysfunction and reduced lifespan.
- Increased mitochondrial ROS was observed, and this toxicity was preventable with antioxidant treatment.
- Non-amyloidogenic LCs or LCs with different organ tropism did not affect pharyngeal pumping.
Conclusions:
- C. elegans serves as a promising surrogate model for investigating the heart-specific toxicity of amyloidogenic LCs.
- This nematode-based assay facilitates the rapid screening of novel therapeutic strategies for AL amyloidosis-related cardiomyopathy.
- The findings highlight the role of mitochondrial ROS in LC-induced cardiac dysfunction.
